07/01/2025 15:00
Gogo Galileo HDX Coming to Cessna Citation Jet Models

Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced Gogo Galileo HDX will be available for aftermarket installation on Cessna Citation jets after Federal Aviation Administration (FAA) Supplemental Type Certification (STC) expected in late 2025. The global Low Earth Orbit (LEO) solution allows customers to enjoy one of the best possible in-flight connectivity and aviation experiences, no matter where their journey takes them. This press release features multimedia. View t...

05/15/2025 18:00
Cessna Citation CJ4 Gen3 Flight Test Program Advances Through Milestones as Second Test Article Takes Flight

Textron Aviation today announced a major program milestone for the Cessna Citation CJ4 Gen3 flight test program with the successful first flight of a second test article — P1. Testing on the P1 aircraft will focus on avionics, human factors and interiors. The Citation CJ4 Gen3 business jet is designed to keep pilots a step ahead in the cockpit by offering the next-generation Garmin G3000 PRIME avionics along with the most standard features in its class. This press release features multimedia. V...

05/21/2025 09:00
Forrester Announces The EMEA Recipients Of Its 2025 Customer-Obsessed Enterprise Award

Forrester (Nasdaq: FORR) today announced that Brenntag and e& are the winners of its 2025 Customer-Obsessed Enterprise Award for Europe, Middle East, and Africa (EMEA). The award recognises organisations that place their customers at the centre of their leadership, strategy, and operations to drive business outcomes, including building sustainable growth, customer loyalty, and employee engagement. Both recipients will be celebrated at CX Summit EMEA, a leading event for CX, B2C marketing, a...

05/15/2025 18:23
DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu

DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded ...

05/15/2025 18:18
Ras Al Khaimah’s Strong Economic and Investment Environment Validated by Fitch Affirmation of ‘A+’ Credit Rating, With Stable Outlook

Ras Al Khaimah’s strategic approach to sustainable, cross-sector growth and strong economic and investment environment has been validated by international credit rating agency Fitch, which reaffirmed the rating at ‘A+’ with a stable outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515907689/en/Ras Al Khaimah’s strong economic and investment environment validated by Fitch affirmation of ‘A+’ credit rating, with Stable Outloo...

06/05/2025 20:00
BGO Announces US$5.1 Billion Capital Raise for Its Asia Value-Add Real Estate Strategy, Marking Largest Closed-End Fundraise in Firm’s History

BGO today announced the final close of BentallGreenOak Asia IV (“BGO Asia Fund IV” or the “Fund”), its flagship Asia-focused value-add real estate strategy, raising over US$5.1 billion in total capital commitments for the Fund and co-investment sidecars. The Fund represents the largest closed-end capital raise in BGO’s history, underscoring the firm’s history and reputation as a premier global real estate investment manager in Asian markets. BGO Asia Fund IV targets value-add opportunities in...

05/15/2025 18:30
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for th...

05/27/2025 01:00
Acceleronix to Showcase Innovative IoT Solutions at CommunicAsia 2025 in Singapore

Acceleronix, a global leader in IoT solutions and services, is excited to announce its participation in CommunicAsia, taking place on May 27th in Singapore, presenting its comprehensive offerings, including the Acceleronix Core PaaS/SaaS, Connectivity Management Platform (CMP), and connectivity solutions. These services are designed to simplify the design and go-to-market processes for OEMs and ODMs across the Asia-Pacific region and beyond. “We’re excited to be at CommunicAsia in Singapore, ...

05/27/2025 01:00
Quectel Highlights Advanced IoT Modules, Antenna, GNSS, and 5G Solutions at CommunicAsia Singapore

Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce its participation in the CommunicAsia event held in Singapore, where it will showcase its comprehensive portfolio of IoT products and services designed to help customers build a smarter, more connected world. “We’re excited to welcome attendees back to our stand at CommunicAsia this year, where we’ll be showcasing Quectel’s latest innovations in IoT,” said Yasu Okada, Senior Sales Director APAC at Quectel Wire...